Risk-informed credibility goals for finite element simulation of rib bone plates: a case study in applying ASME V&V 40 to ASTM F382 testing
- 1Department of Biomedical Engineering, Graduate School, Pusan National University, Busan, Republic of Korea
- 2Department of Biomedical Engineering, School of Medicine, Pusan National University, Busan, Republic of Korea
- 3In Silico Medicine Lab, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
Abstract
IntroductionWhile Computational Modeling and Simulation (CM&S) holds significant potential as key evidence in the design and regulatory approval process for medical devices, establishing the credibility of these results remains paramount. This study presents a case study applying the ASME V&V 40 risk-based framework to the evaluation of the four-point bending performance of rib bone plates.MethodsWe established two distinct Contexts of Use (COUs) for a Class III rib bone plate. COU 1 (Design Change) utilizes CM&S as stand-alone evidence for a design change (increasing the number of holes), corresponding to a High-Medium model risk. Conversely, COU 2 (Product Line Extension) employs CM&S as supplementary evidence for product line expansion (varying bending shapes), corresponding to a Medium-Medium model risk. To meet the credibility requirements commensurate with each COU, we systematically performed Numerical Code Verification (NCV), calculation verification (discretization and solver errors), sensitivity analysis, Uncertainty Quantification (UQ), and validation of the Finite Element Analysis (FEA) model using ASTM F382 bench testing.ResultsVerification activities confirmed numerical stability with an NCV error of 0.704%. Validation results demonstrated that the FE model agreed with experimental four-point bending results within 5% error. For key Quantities of Interest such as bending stiffness, the validation metric (|E|/Uval < 1) further supported model adequacy under the stated Context of Use.DiscussionConsequently, in COU 1, where the Question of Interest (QOI) is whether increasing the hole count degrades performance, the model predicted a negligible impact (<0.2%), illustrating how CM&S may support regulatory decisions on such design changes; as this prediction was not accompanied by physical testing of the extended configurations, experimental confirmation would provide complementary evidence. In COU 2, where the QOI is whether the model can predict the performance of new pre-contoured shapes, errors within the 10% threshold established for this COU support the use of the model as supplementary evidence. This case study illustrates an approach to defining the role of CM&S based on risk and tailoring corresponding VVUQ activities to secure the credibility of data submitted for medical device regulations.
Related
- A Differentiable, GPU-Accelerated Finite-Element Formulation in JAX for Large-Deformation Shells with Contact: Application to Patient-Specific Aortic Valve Simulation
- Structure-Informed Stress-Testing of the Standard Numbering Scheme for Class B β-Lactamases Using AlphaFold2
- The Gendered Credibility Paradox of Suicide: A Teaching Case from Brigitte Bardot’s La Vérité
- A review on applying immunological methods in animal research
- The weight of words: Applying concreteness to elite media language
BibTeX
@article{park2026riskinformed,
title = {{Risk-informed credibility goals for finite element simulation of rib bone plates: a case study in applying ASME V&V 40 to ASTM F382 testing}},
author = {Jun Sung Park and Chiseung Lee and Chiseung Lee},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
month = oct,
doi = {10.3389/fbioe.2026.1875854},
url = {https://doi.org/10.3389/fbioe.2026.1875854},
note = {CC BY},
}
RIS
TY - JOUR
TI - Risk-informed credibility goals for finite element simulation of rib bone plates: a case study in applying ASME V&V 40 to ASTM F382 testing
AU - Jun Sung Park
AU - Chiseung Lee
AU - Chiseung Lee
PY - 2026
DA - 2026/10/26
JO - Frontiers in Bioengineering and Biotechnology
DO - 10.3389/fbioe.2026.1875854
UR - https://doi.org/10.3389/fbioe.2026.1875854
AB - IntroductionWhile Computational Modeling and Simulation (CM&S) holds significant potential as key evidence in the design and regulatory approval process for medical devices, establishing the credibility of these results remains paramount. This study presents a case study applying the ASME V&V 40 risk-based framework to the evaluation of the four-point bending performance of rib bone plates.MethodsWe established two distinct Contexts of Use (COUs) for a Class III rib bone plate. COU 1 (Design Change) utilizes CM&S as stand-alone evidence for a design change (increasing the number of holes), corresponding to a High-Medium model risk. Conversely, COU 2 (Product Line Extension) employs CM&S as supplementary evidence for product line expansion (varying bending shapes), corresponding to a Medium-Medium model risk. To meet the credibility requirements commensurate with each COU, we systematically performed Numerical Code Verification (NCV), calculation verification (discretization and solver errors), sensitivity analysis, Uncertainty Quantification (UQ), and validation of the Finite Element Analysis (FEA) model using ASTM F382 bench testing.ResultsVerification activities confirmed numerical stability with an NCV error of 0.704%. Validation results demonstrated that the FE model agreed with experimental four-point bending results within 5% error. For key Quantities of Interest such as bending stiffness, the validation metric (|E|/Uval < 1) further supported model adequacy under the stated Context of Use.DiscussionConsequently, in COU 1, where the Question of Interest (QOI) is whether increasing the hole count degrades performance, the model predicted a negligible impact (<0.2%), illustrating how CM&S may support regulatory decisions on such design changes; as this prediction was not accompanied by physical testing of the extended configurations, experimental confirmation would provide complementary evidence. In COU 2, where the QOI is whether the model can predict the performance of new pre-contoured shapes, errors within the 10% threshold established for this COU support the use of the model as supplementary evidence. This case study illustrates an approach to defining the role of CM&S based on risk and tailoring corresponding VVUQ activities to secure the credibility of data submitted for medical device regulations.
SN - 2296-4185
ER -